Foreskin Graft Tubularized Incised Plate Urethroplasty vs Tubularized Incised Plate for Primary Hypospadias (FGTIP-TIP)
Launched by HOSPITAL INFANTIL DE MEXICO FEDERICO GOMEZ · Jul 14, 2015
Trial Information
Current as of June 10, 2025
Unknown status
Keywords
ClinConnect Summary
Urethroplasty technique more used in the world for hypospadias repair is Tubularized Incised Plate described by Snodgrass in 1994. Kolon and Gonzales described a technical modification to the TIP in 2000, which is called grafting foreskin.
There are characteristics of the glans and urethral plate favoring the development of complications. In this study the researchers include patients with primary hypospadias, with these characteristics above, and compare two surgical techniques: TIP vs FG-TIP.
The main aim is to determine the efficacy (functional and cosmetic) and safety (complications) ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with hypospadias without previous surgery
- • Hypospadias with width of urethral plate ≤ 7 mm, width of glans ≤ 14 mm, and urethral plate depth shallow o moderate.
- Exclusion Criteria:
- • Patients diagnosed with hypospadias and severe psychomotor development delay
- • Patients with disorders of sexual development without gender assignment
About Hospital Infantil De Mexico Federico Gomez
Hospital Infantil de México Federico Gómez is a leading pediatric healthcare institution dedicated to advancing the field of child health through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital focuses on developing and evaluating new treatments and therapies to improve health outcomes for children. With a commitment to excellence, the institution combines clinical expertise with rigorous scientific methodology, fostering collaboration among healthcare professionals, researchers, and academic partners to address pressing pediatric health challenges. Its mission is to enhance the quality of life for children through cutting-edge research and compassionate care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mario E Rendón Macías, MD MsC
Study Chair
CMNXXI, IMSS
Onofre Muñoz Hernández, MD MsC
Study Director
Hospital Infantil de Mexico Federico Gomez
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials